These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27215488)

  • 1. Progresses in vaginal microflora physiology and implications for bacterial vaginosis and candidiasis.
    Ventolini G
    Womens Health (Lond); 2016 Jun; 12(3):283-91. PubMed ID: 27215488
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaginitis.
    Hainer BL; Gibson MV
    Am Fam Physician; 2011 Apr; 83(7):807-15. PubMed ID: 21524046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulvovaginal candidiasis and bacterial vaginosis.
    Nyirjesy P
    Infect Dis Clin North Am; 2008 Dec; 22(4):637-652. PubMed ID: 18954756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to diagnose and treat aerobic and desquamative inflammatory vaginitis.
    Mason MJ; Winter AJ
    Sex Transm Infect; 2017 Feb; 93(1):8-10. PubMed ID: 27272705
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of lactobacilli and probiotics in maintaining vaginal health.
    Borges S; Silva J; Teixeira P
    Arch Gynecol Obstet; 2014 Mar; 289(3):479-89. PubMed ID: 24170161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
    van Schalkwyk J; Yudin MH;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):266-274. PubMed ID: 26001874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymol, eugenol and lactobacilli in a medical device for the treatment of bacterial vaginosis and vulvovaginal candidiasis.
    Murina F; Vicariotto F; Di Francesco S
    New Microbiol; 2018 Jul; 41(3):220-224. PubMed ID: 29874389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal infections update.
    Mashburn J
    J Midwifery Womens Health; 2012; 57(6):629-634. PubMed ID: 23094602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the vaginal microbiome in clinical diagnosis and management of vaginal infectious diseases.
    Li T; Liu ZH; Li K; Bai HH
    Chin Med J (Engl); 2019 May; 132(9):1100-1103. PubMed ID: 30896565
    [No Abstract]   [Full Text] [Related]  

  • 10. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner.
    Doerflinger SY; Throop AL; Herbst-Kralovetz MM
    J Infect Dis; 2014 Jun; 209(12):1989-99. PubMed ID: 24403560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors.
    Donders G; Bellen G; Neven P; Grob P; Prasauskas V; Buchholz S; Ortmann O
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2023-8. PubMed ID: 26223323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does probiotics work for bacterial vaginosis and vulvovaginal candidiasis.
    Han Y; Ren QL
    Curr Opin Pharmacol; 2021 Dec; 61():83-90. PubMed ID: 34649216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The correction of dysbiosis of the female reproductive tract by using an estradiol-containing preparation].
    Bukharin OV; Konstantinova OD; Kremleva EA; Cherkasov SV
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):100-2. PubMed ID: 10808588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the vaginal microbiota with probiotics as a means to counteract infections.
    Reid G; Dols J; Miller W
    Curr Opin Clin Nutr Metab Care; 2009 Nov; 12(6):583-7. PubMed ID: 19741517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaginal microbicenosis and its disturbances. Etiology, pathogenesis, clinical data, laboratory diagnosis].
    Nazarova EK; Gimmel'farb EI; Sozaeva LG
    Antibiot Khimioter; 2002; 47(4):34-42. PubMed ID: 12369144
    [No Abstract]   [Full Text] [Related]  

  • 16. Could probiotics be an option for treating and preventing urogenital infections?
    Reid G; Bruce AW
    Medscape Womens Health; 2001 Oct; 6(5):9. PubMed ID: 11698931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis.
    Ehrström S; Daroczy K; Rylander E; Samuelsson C; Johannesson U; Anzén B; Påhlson C
    Microbes Infect; 2010 Sep; 12(10):691-9. PubMed ID: 20472091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil Gelatinase-Associated Lipocalin Concentration in Vaginal Fluid: Relation to Bacterial Vaginosis and Vulvovaginal Candidiasis.
    Beghini J; Giraldo PC; Linhares IM; Ledger WJ; Witkin SS
    Reprod Sci; 2015 Aug; 22(8):964-8. PubMed ID: 25670719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting edge: the vaginal microflora and bacterial vaginosis.
    Verstraelen H
    Verh K Acad Geneeskd Belg; 2008; 70(3):147-74. PubMed ID: 18669158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of diet and probiotics in prevention and treatment of bacterial vaginosis and vulvovaginal candidiasis in adolescent girls and non-pregnant women.
    Mizgier M; Jarzabek-Bielecka G; Mruczyk K; Kedzia W
    Ginekol Pol; 2020; 91(7):412-416. PubMed ID: 32779162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.